Full text is available at the source.
Abstract
The developed ratiometric electrochemical biosensor achieves a linear response from 0.01 pM to 100 pM of SARS-CoV-2 N-protein with a detection limit of 1.3 × 10⁻¹⁰ pM.
- The biosensor utilizes target-activated CRISPR-Cas12a activity for detecting the N-protein.
- Methylene blue molecules provide an initial electrochemical signal by binding to guanine bases of a hairpin oligonucleotide.
- CRISPR-Cas12a activation leads to the hybridization of a ferrocene-labeled indicator oligonucleotide, displacing methylene blue.
- This displacement results in a measurable decrease in methylene blue current and an increase in ferrocene current.
- The Fc/MB ratiometric signal correlates with increasing levels of the target N-protein.
- Clinical feasibility for detecting N-protein was demonstrated using inactivated cell-cultured SARS-CoV-2.
Simplified